Managing Safety and Quality of Life With Cemiplimab in Advanced NSCLC
Panelists discuss how balancing survival benefits with quality of life involves careful monitoring of treatment-related adverse effects. Managing immune-related adverse events in patients on immune checkpoint inhibitors like cemiplimab requires early detection, timely intervention and proactive strategies to minimize impact on outcomes.
Video content above is prompted by the following:
- How are potential survival benefits balanced with impacts on patients’ quality of life, particularly in the context of treatment-related adverse effects?
- How do you approach the management of immune-related adverse events in patients receiving immune checkpoint inhibitors like cemiplimab?
- What proactive strategies do you use to minimize the impact of treatment-related adverse events on patient outcomes?
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
